跳至主要内容
临床试验/NCT05274919
NCT05274919招募中不适用

Vascular Signature Mapping of Brain Tumor Genotypes

Leiden University Medical Center2 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2022年8月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
180
试验地点
2
主要终点
Vessel architecture

研究概览

简要总结

A glioma is a primary brain tumor in adults that is characterized by a highly variable, but overall poor survival. The optimal timing of treatment is in part determined by the expected biological behavior of the tumor. At present the expected biological behavior, determined by the tumor genotype, can only be determined by tissue analysis, which requires brain surgery. Non-invasive and improved diagnostic methods are sought to obtain insight into the molecular profile of the tumor and the expected biological behavior to avoid surgery performed solely for diagnostic purposes. Vascularization is an important aspect of the biological behavior of a primary brain tumor. Tumor vascularization characteristics can be assessed by Magnetic Resonance Imaging (MRI), but with the currently available technology this can only be achieved with unacceptably long scan times. In this proposal, the investigators will develop and optimize a novel MRI protocol to gather a large set of quantitative vascularization parameters within an acceptable scan time. The hypothesis is that from such a 'vascular signature' the tumor genotype can be inferred by means of machine learning.

详细描述

Objective of the study:

The primary objective is to develop and clinically validate a fast multi-parametric MRI acquisition technique, for non-invasive and comprehensive characterization of the tumor's vascularization, 'vascular signature mapping', at 3 Tesla (3T) and 7 Tesla (7T) MRI.

The secondary objective is to limit difficult and time-consuming visual interpretation of the acquired vascular information by developing a computer-aided diagnostic algorithm that automatically and accurately predicts the brain tumor genotype from the vascular signature maps.

Study design:

The study 'Vascular Signature Mapping for Brain Tumor Genotypes' is a multi-center observational diagnostic study, which consists of two parts. The first part of this study aims to develop and optimize a new MRI protocol that will exploit the effect of contrast agent on the MRI signal to infer information on the vascular properties of a tumor. It combines scans during the pre-contrast injection phase, the dynamic phase during and right after contrast agent injection, as well as the quasi static post-contrast phase. This research will focus on studying the optimal way of encoding the vascular architecture into the MRI signal and the decoding approach, In addition, the image processing methodology will be optimized. The second part of this study is a proof-of-concept clinical study. This part aims to link the vascular parameters with molecular profiles of tumors by using the collected data for the development of machine learning algorithms for predicting the tumor's genotype based on its vascular signature.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for brain MRI with contrast injection as part of the clinical diagnostic procedure (cohort 1)
  • Patients diagnosed with suspected glioma scheduled for brain MRI as part of the clinical diagnostic procedure (cohort 2)
  • Patients with (suspected) glioma referred for tumor biopsy or resection (cohort 3)
  • Age ≥ 18 years (all cohorts)
  • Signed informed consent (all cohorts)

排除标准

  • Subjects with contra-indications for an MRI exam
  • Subjects with reduced kidney function because of the risk on developing nephrogenic systemic fibrosis (NSF) under gadolinium-based contrast injection
  • Subjects with pregnancy
  • Subjects undergoing a clinical protocol that requires scanning during CA injection (cohort 1)

结局指标

主要结局

Vessel architecture

时间窗: 4 years

Structure of vessels and tortuosity

Transit time parameters

时间窗: 4 years

Timing parameters used to characterize the tumor vasculature

Vascular oxygenation level

时间窗: 4 years

Oxygen-related parameters that describe the tumor's vasculature

Cerebral blood volume

时间窗: 4 years

To characterize the tumor's vasculature

Cerebral blood flow

时间窗: 4 years

To characterize the tumor's vasculature

Optimized MR protocol

时间窗: 6 months

MR protocol optimized for SNR and the ability to obtain vascular information

次要结局

  • Tumor histology(4 years)
  • Tumor molecular parameters(4 years)
  • Basic subject characteristics(4 years)
  • Treatment information(4 years)
  • Tumor progression scored on follow-up MR scan(4 years)
  • Radiation necrosis evaluated on follow-up MR scan(4 years)
  • Mortality(4 years)
  • KPS score at follow-up of 3 and 6 months(4 years)

研究者

发起方
Leiden University Medical Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthias van Osch

Prof. Dr. Ir. Matthias van Osch

Leiden University Medical Center

研究点 (2)

Loading locations...

相似试验